Daniel Arendt , PharmD
Assistant Professor
Assistant Professor
Office: Kowalewski Hall #183
Twitter Handle: @ArendtDr
Phone 513-558-7141
Email arendtdl@ucmail.uc.edu
Professional Summary
Dr. Daniel Arendt (he/him) is an Assistant Professor of Pharmacy Practice and Administrative Sciences with a focus in Pain Management and Opioid Stewardship at the University of Cincinnati James L. Winkle College of Pharmacy.
Dr. Arendt, originally from Buffalo, NY, earned both his Bachelor of Science in Pharmaceutical Sciences and his Doctor of Pharmacy degree from The University of Toledo. After graduating from pharmacy school, Dr. Arendt completed a PGY-1 and PGY-2 Pharmacy Residency program specializing in Internal Medicine and Academia at University Hospitals Geauga Medical Center and Northeast Ohio Medical University.
Within the college of pharmacy, he teaches a variety of subjects including pain management, medical ethics, and evidence based medicine. Dr. Arendt serves on the PharmD admissions committee as well as the faculty development and recognition committee and the assessment committee. In addition to his roles within the college, Dr. Arendt serves as the pain stewardship clinical pharmacy specialist at University of Cincinnati Medical Center. As the pain stewardship pharmacist for UCMC, he serves as a chair of the pain stewardship committee for UC Health, where he works to develop a system-wide pain stewardship program that optimizes the practice of pain management and reduces opioid-related adverse events within not only the UC health system, but the greater Cincinnati community. Outside of the University, Dr. Arendt serves as the director of the legislative affairs division of The Ohio Society of Health-System Pharmacists and is a proud advocate of harm reduction.
Education
PharmD: The University of Toledo 2018
B.S. in Pharmaceutical Sciences: The University of Toledo 2016
Research and Practice Interests
Pain Management
Substance Use Disorder
Harm Reduction
Publications
Peer Reviewed Publications
Arendt DD, Boyle JA. (2021. ) When resiliency is not enough: Addressing the structure of a residency program and its contribution to pharmacy resident burnout. Published in The American Journal of Health System Pharmacists. More Information
Arendt DD, Boyle JA (2022. ) Opportunity cost. Published in The American Journal of Health System Pharmacists. More Information
Arendt DD (2022. ) Pain and prejudice: Exploring the racist origins of US drug policy and its impact on the modern opioid epidemic. Published in The Journal of the American College of Clinical Pharmacy. More Information
Arendt DD (2022. ) Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.J. Am. Pharm. Assoc., , 0 (5 ) ,118 More Information
Statczar A, Welch K, Arendt D, et al (2023. ) Assessing the effectiveness of a consultant pharmacist-led opioid stewardship protocol in skilled nursing facilities. Sr. Care. Pharm., ,
Other Publications
Arendt DD (2022. ) The origins of U.S. drug policy and its ties to systemic racism .
Arendt DD (2021. ) Naloxone's Availability via Pharmacies and the Stigma Associated With It .
Naloxone's Availability via Pharmacies and the Stigma Associated With It
Arendt DD (2021. ) Harm Reduction and Naloxone Access in Opioid Management .
Presentations
Invited Presentations
Boyle J, Cain J, English D, Soric M, Arendt D, (2020. ) The Final Missing Piece in the Well-being Puzzle: What Leadership Can Do . Presented at the American Association of Colleges of Pharmacy (AACP) Annual Meeting,
Arendt DD (2019. ) Emerging Trends of Tick-Borne Diseases: A Review of Their Impact on Health in Ohio . Presented at The Ohio Pharmacists Association: Pharmacy Technician Education Seminar,
Arendt DD, Klarich AM (2019. ) Emerging Trends of Tick-Borne Diseases: A Review of Their Impact on Health in Ohio . Presented at The Ohio Society of Health System Pharmacists Annual Meeting,
Arendt DD (2021. ) Risk Factors and Prevention Strategies of Psychiatric Destabilization and Substance Use . Presented at The American College of Clinical Pharmacy Annual Meeting,
Arendt DD, Turner-Bicknell T, Bachmeyer S, et al. (2021. ) Implementation of a Harm Reduction Dispensing Machine . Presented at The Transforming Care Conference by Equitas Health,
Arendt DD, Turner-Bicknell T, Goeller R, et al. (2022. ) Implementing a Harm Reduction Supply Dispensing Machine Pilot Program. Presented at Ohio's Opiate and Other Drug Conference,
Arendt DD (2021. ) Misused & Misunderstood: Combatting the Opioid Epidemic . Presented at The Tri-County Pharmacists Association Meeting,
Arendt DD (2021. ) Pain and Prejudice – Inequity in the Opioid Epidemic . Presented for The UC Alumni Association - Health Inequities Series,
Arendt DD (01-18-2023. ) (In Press. ) The Time is Now: Updated CDC Clinical Practice Guidelines for Prescribing Opioids for Pain. APhA Hot Topics Webinar Series, Virtual. Conference. . Level:National
Arendt DD (2022. ) Pain Stewardship and The Hospital Pharmacist . Presented at The University at Texas Hospital Practice Seminar,
Poster Presentations
Arendt D, Soric M (2018. ) Evaluating the Potential Role of Statin Therapy in the Reduction of Gentamicin-Induced Nephrotoxicity: A Retrospective Cohort Study . Poster Presented at The American Society of Health System Pharmacists Midyear Clinical Meeting,
Arendt D, Everly L (2018. ) Impact of a Parenteral Opioid Mitigation Strategy on Usage Rates in a Community Hospital Setting . Poster Presented at The Vizient Consortium Pharmacy Network Annual Meeting,
Arendt D, Soric M, Divoky P (2019. ) A Cross-Section of Asthma and COPD: Inhaled Corticosteroid Prescribing Patterns in the United States . Poster Presented at The American Society of Health System Pharmacists Midyear Clinical Meeting,
Brizzi MB, Arendt DD, Wiest M. (2021. ) Implementation of a Pharmacist-Led Pain Stewardship Committee at a Multi-Site Academic Medical Center . Poster Presented at The ACCP Global Conference,
Howell E, Brizzi M, Lyons M, Arendt DD, Stewart D. (2021. ) Evaluation of the impact of pharmacist interventions on naloxone prescribing in the ambulatory setting . Poster Presented at The ACCP Global Conference,
Howell E, Brizzi M, Lyons M, Arendt DD, Stewart D. (2021. ) Increasing Access to Naloxone through a Best Practice Advisory . Poster Presented at The Vizient Consortium Pharmacy Network Annual Meeting,
Howell E, Brizzi M, Lyons M, Arendt DD, Stewart D. (2022. ) Evaluation of the impact of pharmacist interventions on naloxone prescribing in the ambulatory setting . Poster Presented at The Ohio Hospital Association,
Honors and Awards
09-2017 Edward Rowe Award. Awarded by The National Association of Boards of Pharmacy
07-2018 Walmart Scholar. Awarded by The American Association of Colleges of Pharmacy
02-2021 Faculty Excellence Award. Awarded by The UC Chapter of The Rho Chi Honor Society
04-2021 Faculty Excellence in Teaching Award. Awarded by The University of Cincinnati PharmD Class of 2022
02-2022 Faculty Lecturer Award. Awarded by The UC Chapter of The Rho Chi Honor Society
04-2022 Faculty Excellence in Teaching Award. Awarded by The University of Cincinnati PharmD Class of 2023
Post Graduate Training and Education
PGY-1: Pharmacy Practice Residency., Completed at University Hospitals: Geauga Medical Center, ,
PGY-2: Internal Medicine and Academia., Completed at University Hospitals Geauga Medical Center and Northeast Ohio Medical University, ,
Keywords
Opioid / Opioids / Fentanyl / Harm Reduction / Pain Management / Pain / Multimodal Treatment / Pharmacy / Pharmacist / Substance Use Disorder / Addiction / Clinical Pharmacy / Clinical Pharmacy Specialist /
Professional Affiliation
'22-23: Director of Legislative Affairs. The Ohio Society of Health-System Pharmacists,
Courses Taught
-PHTH-9070 THERAPEUTICS IV Level:Graduate
-PHRX-7050 PHARMACY ETHICS
Contact Information
Academic - Office: Kowalewski Hall #183
Twitter Handle: @ArendtDr
Phone: 513-558-7141
arendtdl@ucmail.uc.edu